WebDisclosure WebDisclosure
Basculer en Français
10964 Companies
240021 Keywords
168770 Articles
129127 Press releases
Headlines Articles Press releases Zorts Sports Remove
  1. Home
  2. Companies
  3. Zorts Sports
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/01/2024 at 15:05, 2 years 6 months ago

    Zorts Sports Launches Initiative to Improve Youth Sports Safety and Integrity

    Zorts Sports Youth Sports Safety Sports Management Software Player Verification Sportsmanship
  • BRIEF

    published on 03/01/2024 at 15:05, 2 years 6 months ago

    Zorts Sports lance une initiative pour améliorer la sécurité et l'intégrité des sports des jeunes

    Zorts Sports Sécurité Sportive Des Jeunes Logiciel De Gestion Sportive Vérification Du Joueur Esprit Sportif
  • PRESS RELEASE

    published on 03/01/2024 at 15:00, 2 years 6 months ago

    Zorts Sports Tackles Youth Sports Safety Concerns With Innovative Solutions

    Zorts, a leading sports management software provider, commits to enhancing safety and integrity in youth sports with innovative tools. Advanced Zorts Player Cards & Coach Cards verify participants' identities and ages, deterring misconduct
    Youth Sports Integrity Sports Management Software Zorts Safety
    Logo of Zorts Sports
Accesswire
  • Published on 09/11/2026 at 04:00, 6 hours 11 minutes ago

    Torq Announces Debt Settlement and Corporate Update

  • Published on 09/10/2026 at 22:25, 11 hours 46 minutes ago

    Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer

  • Published on 09/10/2026 at 17:46, 16 hours 25 minutes ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 18 hours 51 minutes ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 19 hours 11 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 09:20, 51 minutes ago

    Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines

  • Published on 09/11/2026 at 09:05, 1 hour 6 minutes ago

    ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size

  • Published on 09/11/2026 at 09:00, 1 hour 11 minutes ago

    Homann Holzwerkstoffe publishes its 2026 half-year report

  • Published on 09/11/2026 at 09:00, 1 hour 11 minutes ago

    Picton Property Income Limited - Removal

  • Published on 09/11/2026 at 09:00, 1 hour 11 minutes ago

    Official List Notice

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 3 hours 11 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 3 hours 11 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 3 hours 11 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 3 hours 11 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 14 hours 41 minutes ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy